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Summary
Background: Predischarge exercise testing early after myocardial infarction is useful for risk stratification, exercise 
prescription, and assessment of prognosis and treatment.
Objective: The objective of this study was to compare the findings of exercise testing early after myocardial infarction with 
those of echocardiography, electrocardiographic monitoring (24-hour Holter monitoring) and coronary angiography.
Methods: We evaluated 60 cases (mean age of 51.42 ± 9.34 years), of which 46 were males (77%). The symptom-limited 
maximal exercise test according to the Naughton protocol12 was performed between the sixth day of hospitalization and 
hospital discharge, with the patients on medication. During hospitalization, the patients underwent echocardiography, 
electrocardiographic monitoring and coronary angiography. 
 The significance level was set at 0.05 (α = 5%).
Results: Exercise testing had a poor performance in the detection of multivessel coronary artery disease (sensitivity, 
42%; specificity, 69%). No significant differences were found when the presence of ischemia on exercise test was 
compared with multivessel coronary disease, complex ventricular arrhythmias on electrocardiographic monitoring, and 
the finding of an ejection fraction lower than 60% on echocardiography (p = 0.56), as well as with the presence of 
multivessel lesions, complex ventricular arrhythmias on electrocardiographic monitoring and abnormal ejection fraction 
on echocardiography (p = 0.36).
Conclusion: The presence of ischemia during exercise testing was associated with the occurrence of ventricular 
arrhythmias on electrocardiographic monitoring, with reduced ejection fraction on echocardiography, as well as with 
the presence of multivessel coronary lesions, which constitutes an indicator of a high coronary risk. (Arq Bras Cardiol 
2008; 90(3):176-181)
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Introduction
Predischarge exercise testing (ET) early after myocardial 
infarction (MI) is useful for risk stratification and assessment of 
prognosis. In ET early after MI, ST-segment depression, angina 
pectoris, abnormal systolic blood pressure (SBP) response and 
reduced aerobic capacity are related to adverse outcomes1-
6. Functional assessment enables treatment evaluation and 
prescription of work, recreation and rehabilitation activities7,8. 
ET early after myocardial infarction is a safe procedure, with a 
mortality rate of 0.03% to 0.12%9,10, morbidity of 0.09%9, and 
incidence of subacute stent thrombosis of 0.02%11.
The objective of this study was to compare the findings 
of ET early after MI with those of echocardiography (ECHO), 
electrocardiographic monitoring (24-hour Holter monitoring) 
(ECGM), and coronary angiography (CAG).
Methods
This prospective cross-sectional study included a series 
of consecutive patients of the Coronary Unit of Hospital São 
Paulo. Of the 278 patients admitted with a diagnosis of MI, 
60 were evaluated (mean age of 51.42 ± 9.34 years); 46 were 
males (77%). The organization chart for exclusion of cases is 
shown in Figure 1.
Diagnosis of MI was confirmed by the presence of two or 
more of the following criteria: 1) Chest or retrosternal pain, 
whether constricting or burning; radiating to the upper limbs, 
neck and back or not, lasting > 30 minutes; and not relieved 
by vasodilators; 2) ST-segment elevation > 1 mV in ≥2 leads; 
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ECHO was performed using parasternal (long and short 
axes) and apical (four and two-chamber) views, with an 
Ultramark 4 CV (Bothell, WA) equipment with a 3-MHz 
transducer. Ejection fraction was calculated using the cube 
method (reference values: 0.60 to 0.80)14.
ECGM was recorded in the V1 and CM leads, using 
a Dynamis 2000 – Cardios Sistemas (Sao Paulo, Brazil) 
equipment and a DMI Cardios model Cardiology 4300 
(Cardios Sistemas, SP, Brazil) analyzer.
CAG was performed using the Sones technique in the 
left anterior oblique, right anterior oblique and left lateral 
views. Obstructions > 70% of the arterial lumen were 
considered significant15.
The following tests were used for the statistical analysis: 
1) Fisher’s exact test for the relationship between the ability to 
detect ventricular arrythmias on ETe and on ECGM; 2) Cochran 
test for the concordance between the assessments carried out 
by ETe, ECHO, ECGM and CAG; 3) Student’s t test for the 
mean endurance time in relation to the CAG, ECHO, abnormal 
ETe, ischemic ETe and ECGM variables; 4) Pearson’s chi square 
test or Fisher’s test for the relationship between the variables 
and the groups established, considering critical endurance 
time values those ≤12; 5) Kruskal-Wallis test and ANOVA for 
comparison of endurance time according to the angiographic 
lesions. Significance level was set at 0.05 (α = 5%).
Results
Exercise Testing
ETs were performed uneventfully 10.85 ± 3.46 days after 
MI (Table I). The ST-segment was normal in 19 cases (31%), 
upsloping in 21 cases (35%), horizontal in 16 cases (27%), 
downsloping in 4 cases (7%), and was considered ischemic 
in 21 patients (35%): 4 upsloping, 13 horizontal and 4 
downsloping. No U-wave inversion was observed. Isolated 
supraventricular extrasystoles were found in five ETe (8%). 
Ventricular arrhythmias were recorded in six cases (10%): 
Lown grade II (4 cases), grade III (one case), and grade IV-A 
(one case). Angina pectoris was present in five patients. In 20 
cases, the SBP increment was < 30 mmHg, and in three cases 
SBP peak was < 110 mmHg.
Echocardiography
Echocardiography recorded enlarged left atrium in six 
patients (10%) and enlarged left ventricle in nine (15%). 
Reduced fractional shortening was observed in 23 cases 
(38%), and reduced ejection fraction in 16 cases (27%). 
Left ventricular segmental motion was abnormal in 56 patients 
(93%) with hypokinesia in 21 cases (35%), akinesia in 11 cases 
(18%) and hypokinesia associated with akinesia in 24 cases 
(40%). Heart valve disease, pericardial diseases and pulmonary 
hypertension were not detected. 
Electrocardiographic Monitoring 
Electrocardiographic monitoring showed sinus rhythm in 
all cases (Table I). Angina was not recorded. Supraventricular 
arrhythmias occurred in 58 patients (96%): isolated 
extrasystoles in 58 (96%), paired extrasystoles in 12 (20%), 
3) Increased CK-MB and CPK levels, two times the normal 
values. Patients aged less than 70 years, in New York Heart 
Association functional class I, with no post-MI angina, complex 
ventricular arrhythmias or electrocardiographic instability were 
included. Patients with chest pain in the three preceding days, 
uncontrolled hypertension, previous revascularization, left 
ventricular thrombus, walking difficulty, disabling disorders for 
the performance of ETe and those who refused to participate 
in the study were excluded. 
ECG showed 38 Q-wave MI (63%), 22 non-Q-wave MI (37%), 
in inferior wall (55%), septal (25%), and lateral wall (3%).
The patients were receiving aspirin (93%), beta blockers 
(83%), nitrates (76%), angiotensin-converting enzyme 
inhibitors (60%) and calcium antagonists (15%). Thirty five 
patients underwent streptokinase thrombolysis (58%).
The study was approved by the Research Ethics Committee 
of Universidade Federal de São Paulo – Escola Paulista de 
Medicina. A written informed consent was obtained from 
all patients.
The patients underwent ET, ECHO, ECGM and CAG prior 
to hospital discharge, on their usual medications.
The symptom-limited maximal exercise test according to 
the Naughton et al12 was performed between the sixth day 
of hospitalization and hospital discharge. The TRACKMASTER 
TM treadmill (Pensacola, Florida) and the APEX 2000 TEB 
System (Sao Paulo, Brazil) with 13 leads (12 conventional 
leads plus CM5) were used. ST-segment alterations ≥ 0.10mV 
(horizontal, depression) or ≥ 0.20mV (elevation) were 
considered significant, and ET with significant ST-segment 
alteration, U-wave inversion and angina were considered 
ischemic. ET with abnormal ST-segment, U-wave inversion, 
angina, grade II-IV ventricular arrhythmias (Lown), and 
abnormal SBP responses (SBP peak < 110 mmHg, SBP 
increment < 30 mmHg)8 were considered abnormal. The 
predicted maximum heart rate was calculated using the 
Karvonen e cols.13 formula.
Fig. 1 - Organization chart representing the exclusion criteria.
Exclusion Criteria:
1. Cardiologic criteria:
	 Heart	Failure	(n	=	58;	21%);
	 Cardiac	Arrhythmias	(n	=	39;	14%);
	 Angina	Pectoris	(n	=	20;	7%);
	 CLBBB	(n	=	3;	1%).
2. Comorbidities:
	 Bone,	muscle	and	joint	diseases	(n	=	19;	7%);
	 Chronic	Obstructive	Pulmonary	Disease	(n	=	14;	5%);
	 Chronic	Renal	Failure	(n	=	9;	3%);
3. Previous Hemodynamic Study	(n	=	33;	12%);
4. Refusal to participate	(n	=	23;	8%).
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paroxysmal tachycardia in 9 (15%). Ventricular arrhythmias 
were recorded in 52 patients (87%): isolated (52 cases, 87%), 
paired (15 cases, 25%), and in clusters (11 cases, 18%). No 
sustained ventricular tachycardia or ventricular fibrillation 
occurred.
Hemodynamic Study
In the hemodynamic study, critical one-vessel lesions were 
recorded in 27 patients (45%), and multivessel lesions in 24 
patients (40%): 1) Left main coronary artery, 1 case (mild); 
2) Anterior descending artery, 32 cases (53%), critical in 25 
cases (78%); 3) Right coronary artery in 28 patients (47%), 
critical in 20 cases (71%); 4) Circumflex artery in 23 patients 
(38%), critical in 16 cases (70%).
The left ventricle was normal in 30 cases (50%), showed a 
mild dysfunction in 15 cases (25%), was moderate in 12 cases 
(20%), and severe in two cases (3%).
Relationships between the results of the procedures
The relationship between the results obtained in ET, ECGM 
and CAG are shown in Tables 2, 3, 4, 5 and 6. No relationship 
was observed between the presence of ventricular arrhythmias 
on ET and on ECGM (Table 2); the occurrence of both was 
independent (p = 0.65%). No difference was found in the 
number of ventricular extrasystoles on the ECGM of patients 
with or without ventricular extrasystoles on ET (1298 ± 80, 
median = 262 vs. 88 ± 325, median = 6, p = 0.23).
No significant associations were found between: 1) The 
number of ventricular extrasystoles on ECGM and ejection 
fraction (r = 0.04); 2) The number of ventricular extrasystoles 
on ECGM and SBP increment (r = -0.16); 3) Ejection fraction 
and SBP increment (r = 0.10). 
ET had a poor performance in the detection of multivessel 
coronary disease (Table 3).  
No significant differences were observed when the 
presence of ischemia on ET was compared with multivessel 
coronary disease on CAG, complex ventricular arrhythmias 
on ECGM, and the occurrence of ejection fraction lower 
than 60% on ECHO (p = 0.56), as well as with the presence 
of multivessel lesions on CAG, complex ventricular 
arrhythmias on ECGM and abnormal ejection fraction on 
ECHO (p = 0.36) (Table 4).
The endurance time was 16.1 ± 4.7 minutes, ranging from 
6 to 21 minutes. It was higher than 12 minutes in 45 patients 
(75%) and ≥15 minutes in 37 cases (62%), and was compared 
to the following variables: 1) CAG, as to the presence or absence 
of critical lesions; 2) ECHO, as to an ejection fraction lower 
than or higher than 60%; 3) Abnormal ET, as to the presence or 
absence of abnormalities; 4) Ischemic ET, as to the presence or 
absence of ischemia; 5) ECGM, as to the presence or absence 
of complex ventricular arrhythmias. Only the differences 
for abnormal and ischemic ET (p = 0.07 and p = 0.08, 
respectively) showed a trend to significance (Table 5). Endurance 
time values equal to or higher than 12 or 15 minutes bore no 
relation to the occurrence of severe coronary lesions on CAG, 
of ejection fraction lower than 60% on ECHO, and of ischemic 
ST-segment on ET. However, they were significant in relation to 
the occurrence of abnormal ET (Table 6).
Discussion
Predischarge ET early after MI is recommended in the 
following situations: 1) Class I, for prognostic assessment, 
physical activity prescription and evaluation of therapy; 
2) Class IIb, for detection of myocardial ischemia after CAG, 
in cases in which the coronary lesions cannot be evaluated; 
3) Class IIb, in patients with ECG changes that can interfere 
with the analysis of the ST-segment; 4) Class III, in cases 
with comorbidities that limit life expectancy or myocardial 
revascularization16.
Table 1 - Exercise test and electrocardiographic monitoring 
variables.
Variable Mean ± SD Median
HRPEAK (bpm) 116 ± 20 112
HRPEAK / HRPREDICTED MAX (%) 67 ± 11 67
SBPREST (mmHg) 114 ± 18 110
SBPPEAK (mmHg) 149 ± 30 148
DPPEAK (mmHg.bpm.10-2) 173 ± 46 176
Δt (days) 11 ± 3 10
HR MIN – ECGM 53 ± 8 54
HR MEAN – ECGM 71 ± 11 72
HR MAX - ECGM 106 ± 20 101
ECGM – Electrocardiographic monitoring (24-hour Holter System); SD – Standard 
deviation; HRPEAK – Peak heart rate; HRPREDICTED MAX – Predicted maximum 
heart rate; SBP – Systolic blood pressure; DP – Double product; �t – Time interval    
between MI and ETE; HRMIN – Minimum heart rate; HRMEAN – Mean heart rate; 
HRMAX – Maximum heart rate.
Table 2 - Incidence of ventricular arrhythmias and complex ventricular arrhythmias on exercise test and on electrocardiographic monitoring 
(24-hour Holter system).
Group AV Group CAV
Variable n % n % Comparative test
ET 4 14.29 1 5.26
p=0.655
ECGM 34 85.71 18 94.74
AV - ventricular arrhythmias; CAV - complex ventricular arrhythmias; ET - exercise test; ECGM - electrocardiographic monitoring (24-hour Holter system).
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Despite the symptom-limited protocol, our findings showed 
a maximum heart rate of 116 ± 20 bpm, corresponding to 66.9 
± 11.2% of the predicted maximum rate, thus complying with 
the established guidelines16. These values were higher than 
those obtained on ECGM. ET early after MI may be performed 
using the Bruce protocol within three days of hospital admission 
with a low incidence of complications. In symptom-limited ET 
early after MI the maximum heart rate reached was 116 ±1bpm 
(72.2 ± 0.8% of the predicted maximum)17.
SBP showed, on average, an increment from 114 ± 18mmHg 
to 149 ± 30mmHg. This increment was abnormal in 33% of 
the cases. This has been attributed to ischemic ventricular 
dysfunction, physical deconditioning, and use of beta-blockers, 
as well as to left ventricular baroceptor alterations8.
The double product provides an estimate of myocardial 
oxygen consumption7. Reference values correspond to levels 
≥ 25000bpm.mmHg8,18. Our patients reached 17335 ± 
4654bpm.mmHg, probably due to factors that influenced 
the heart rate and blood pressure, especially the use of 
beta-blockers11. In general, despite the regional contractility 
alterations, the patients had, preserved ventricular function, 
with reduction of fractional shortening by 38%, of ejection 
fraction by 27%, and of the prevalence of abnormal 
ventriculography of moderate and severe degrees by 23%. 
The use of the planar method for the calculation of ejection 
fraction would have provided more reliable results.
The ability of ET early after MI in the detection of multivessel 
coronary disease showed a sensitivity and specificity of 58% 
and 82%, respectively, for ST-segment alterations, and 40% and 
83% for the occurrence of angina during ET9. Our findings are 
similar, showing a poor performance of ET early after MI, with an 
accuracy of 58%. These results were facilitated by the use of drugs, 
by the test protocol, and by the occurrence of MI in the anterior 
wall. A significant reduction of ET sensitivity was demonstrated 
in patients with pathological Q waves from V1 to V419.
The occurrence of cardiac arrhythmias on ET early after 
MI has been related to myocardial ischemia and ventricular 
dysfunction20,21. Patients with ventricular arrhythmias have 
a high prevalence of infarct-related artery stenosis, peri-
infarction ischemia and ischemia in multivessel distribution21. 
In this study, ventricular arrhythmias were more frequently 
Table 3 - Performance of the exercise test on coronary artery disease.
Variable ACD (%) MV-ACD (%)
Sensitivity 37 42
Specificity 78 69
Positive predictive value 90 48
Negative predictive value 18 64
Efficacy 43 58
ACD - Atherosclerotic coronary disease; MV-CAD - Multivessel ACD.
Table 4 - Variables used in the comparison of endurance time.
Variable Positive Category Negative Category
Coronary angiography Severe ACD No severe ACD
Echocardiography EF < 60% EF > 60%
Abnormal Exercise Test Abnormality during exercise testing No abnormality during exercise testing
Ischemic Exercise Test Ischemia during exercise testing No ischemia during exercise testingo
Electrocardiographic Monitoring (24-hour Holter) Complex ventricular arrhythmia No complex ventricular arrhythmia
ACD - atherosclerotic coronary disease; EF - ejection fraction.
Table 5 - Endurance time values in relation to coronary angiography. echocardiography. electrocardiographic monitoring and ischemic and 
abnormal exercise test variables.
Variable Category Mean SD Median n t test
CAG
+ 14.8 4.8 15.1 24 p=0.1
- 16.9 4.5 18.4 36
ECHO
+ 16.4 3.7 16.0 16 p=0.8
- 16.0 5.0 17.2 40
IET
+ 14.7 5.3 15.2 21 p=0.09
- 16.8 4.2 17.8 39
AET
+ 15.1 5.0 15.1 32 p=0.08
- 17.2 4.0 17.9 28
ECGM
+ 16.0 5.1 17 19 p=0.10
- 16.1 4.5 16.8 41
CAG – Coronary angiography (+. with critical lesions); ECHO – Echocardiography (+. with abnormal ejection fraction); IET – Ischemic exercise test (+. with ischemic ST-segment. 
U-wave inversion and/or angina); AET – Abnormal exercise test (+. with ischemia. ventricular arrhythmia and/or abnormal SBP response); ECGM – Electrocardiographic 
monitoring (24-hour Holter System) (+. with complex ventricular arrhythmia); SD – Standard deviation.
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observed on ECGM. There was no relation between the 
occurrence of arrhythmias on ET and on ECGM. The degree 
of ventricular extrasystoles on ECGM did not show any 
correlation with ejection fraction and SBP increment. The 
sample size may have interfered with these results. 
However, no significant differences were found between 
the procedures, considering ET with myocardial ischemia, 
ECHO with reduced ejection fraction, ECGM with complex 
arrhythmias, and CAG with multivessel lesions. These 
procedures had the same value in the identification of cases 
presenting with alterations. 
Inability to reach a 5-MET workload during ET early after MI is 
related to adverse outcomes7. Patients able to reach 5 to 6 METs 
had a mortality of 1 to 2% in the first year1. Functional capacity 
is a strong predictor of death and reinfarction, irrespective of 
treatment strategy; the prognostic value of ST-segment depression 
is more evident in fibrinolysis-treated patients20.
Endurance time enables the estimation of the aerobic 
capacity7 and is considered predictive of post-infarction 
coronary events2,5,6,7,22. Inability to complete six minutes of 
exercise was predictive of mortality5. In this study, we used 
the Naughton protocol, in which the 5-MET workload would 
correspond to a 12-minute endurance time. No significant 
differences were found in endurance time in relation to the 
presence of ischemia on ET, reduced ejection fraction on ECHO, 
complex ventricular arrhythmia on ECGM and multivessel 
lesions. Patients with ischemic or abnormal ET showed a non-
significant trend to lower values of endurance time. The analysis 
of these results was affected by the sample size. 
In general, our results were influenced by the inclusion 
criteria, which led to an interpretation bias because patients 
with a favorable clinical outcome, occasionally favorable 
prognosis and receiving medication were selected. Repetitive 
ventricular arrhythmias and ST-segment changes are more 
frequent in patients off pharmacological therapy. Drug 
discontinuation is well tolerated soon after MI; however, 
there is a risk that must be taken into account as a criterion 
of drug discontinuation23.
Patients unable to undergo ET early after MI had a higher 
mortality in Froelicher et al1 meta-analysis (1987), in the pre-
thrombolytic era1, and in GISSI-2 and TIMI-2 trials, as well as 
in Arnold et al4 findings (1993), in the thrombolytic era3,6. 
The limitations of the present study were: 1) The conclusions 
are valid in cases of non-complicated MI; 2) Sample size.
Conclusions
In this study, exercise testing early after myocardial infarction 
showed a low value in the detection of multivessel coronary 
artery disease. However, the presence of ischemia during 
the test was associated with the occurrence of ventricular 
arrhythmias on ECGM, with reduced ejection fraction on 
ECHO, and with the presence of multivessel coronary lesions, 
which constitutes an indicator of a high coronary risk. 
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Table 6 - Distribution of frequency of coronary angiography. echocardiography. abnormal exercise test. ischemic exercise test and 
electrocardiographic monitoring variables for the groups with endurance time ≤ 12 minutes and > 12 minutes. and for the groups with 
endurance time ≤ 15 minutes and > 15 minutes.
Group
Variable C
≤ 12 minutes > 12 minutes
CT
≤ 15 minutes > 15 minutes
TC
n % n % n % n %
CAG
+ 8 53.33 16 35.56
p=0.224
12 52.17 12 32.43
p=0.129
- 7 46.67 29 64.44 11 47.83 25 67.57
ECHO
+ 3 21.43 13 30.95
p=0.495
6 27.27 10 29.41
p=0.863
- 11 78.57 29 69.05 16 72.73 24 70.59
AET
+ 11 73.33 21 46.67
p=0.073
16 69.57 16 43.24
p=0.047*
- 4 26.67 24 64.44 7 30.43 21 56.76
IET
+ 7 46.67 14 31.11
p=0.274
10 43.48 11 29.73
p=0.278
- 8 64.44 31 68.89 13 56.52 26 70.27
ECGM
+ 7 46.67 12 26.67
p=0.202
7 30.43 12 32.43
p=0.875
- 8 64.44 33 73.33 16 69.57 25 67.57
C - Category; CT - comparative test; CAG - coronary angiography; ECHO - echocardiography; AET - abnormal exercise test; IET - ischemic exercise test; ECGM - electrocardiographic 
monitoring (24-hour Holter System).
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